{"id":1263,"date":"2026-01-26T21:22:03","date_gmt":"2026-01-26T21:22:03","guid":{"rendered":"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&#038;p=1263"},"modified":"2026-01-26T21:22:03","modified_gmt":"2026-01-26T21:22:03","slug":"medicamente-pentru-slabire-comparand-optiuni-de-top","status":"publish","type":"tty_blog","link":"https:\/\/www.transtoyou.com\/ro\/blog\/sanatate-cronica-metabolica\/medicamente-pentru-slabire-comparand-optiuni-de-top\/","title":{"rendered":"Medicamente pentru Pierdere \u00een Greutate: Compararea celor Mai Bune Op\u021biuni"},"content":{"rendered":"<p>Medicamentele pentru pierderea \u00een greutate, cum ar fi Mounjaro (tirzepatide) \u0219i Ozempic (semaglutide), au c\u00e2\u0219tigat popularitate datorit\u0103 eficien\u021bei lor \u00een gestionarea obezit\u0103\u021bii. Acest ghid exploreaz\u0103 mecanismele lor, rezultatele pierderii \u00een greutate, efectele secundare \u0219i eligibilitatea pentru a te ajuta s\u0103 decizi care ar putea fi potrivit pentru tine.<\/p>\n<p>Peptidul 1 asem\u0103n\u0103tor glucagonului (GLP-1) este \u00een prezent unul dintre cele mai promi\u021b\u0103toare sisteme biologice pentru dezvoltarea farmacoterapiilor eficiente \u00eempotriva obezit\u0103\u021bii. Analogii GLP-1 cu ac\u021biune prelungit\u0103 reduc puternic aportul alimentar \u0219i greutatea corporal\u0103, iar descoperirile recente arat\u0103 c\u0103 administrarea periferic\u0103 a acestor medicamente reduce aportul alimentar \u00een mare parte prin c\u0103i humoral\u0103 implic\u00e2nd ac\u021biunea direct\u0103 asupra receptorilor GLP-1 din creier (GLP-1R).<\/p>\n<h2>Mounjaro vs Ozempic: Care func\u021bioneaz\u0103 mai bine?<\/h2>\n<p><a class=\"always-open-new-tab\"   href=\"\/ro\/product\/mounjaro\"   rel=\"nofollow\">Mounjaro<\/a> folose\u0219te un mecanism de ac\u021biune dual asupra receptorilor GIP \u0219i GLP-1, \u00een timp ce <a class=\"always-open-new-tab\"   href=\"\/ro\/product\/ozempic\"   rel=\"nofollow\">Ozempic<\/a> vizeaz\u0103 doar receptorii GLP-1, ceea ce duce la diferen\u021be \u00een eficacitate. Studiile clinice arat\u0103 c\u0103 Mounjaro ar putea fi mai eficient dec\u00e2t Ozempic \u00een gestionarea nivelurilor de zah\u0103r din s\u00e2nge \u0219i promovarea pierderii \u00een greutate. Ozempic este aprobat pentru a reduce riscurile de evenimente cardiovasculare majore \u0219i complica\u021bii din boli renale, un beneficiu care nu este \u00eemp\u0103rt\u0103\u0219it de Mounjaro. Ambele medicamente sunt tratamente injectabile pe termen lung pentru diabetul de tip 2 <a class=\"always-open-new-tab\"   href=\"\/ro\/treatment\/diabetes\"   rel=\"nofollow\">diabet<\/a> care sunt menite s\u0103 fie utilizate \u00eempreun\u0103 cu schimb\u0103ri \u00een stilul de via\u021b\u0103, cum ar fi o diet\u0103 echilibrat\u0103 \u0219i exerci\u021bii fizice.<\/p>\n<h2>Wegovy sau Saxenda: Care ofer\u0103 o pierdere \u00een greutate mai mare?<\/h2>\n<p>\u00cen mod firesc, majoritatea oamenilor care aleg \u00eentre tratamentele pentru pierderea \u00een greutate doresc s\u0103 \u0219tie care op\u021biune va fi cea mai eficient\u0103. De\u0219i rezultatele vor varia \u00een func\u021bie de greutatea ini\u021bial\u0103, stilul de via\u021b\u0103 \u0219i diet\u0103, <a class=\"always-open-new-tab\"   href=\"\/ro\/product\/wegovy\"   rel=\"nofollow\">Wegovy<\/a> este considerat \u00een general mai eficient dec\u00e2t <a class=\"always-open-new-tab\"   href=\"\/ro\/product\/saxenda\"   rel=\"nofollow\">Saxenda<\/a>. Un studiu de 68 de s\u0103pt\u0103m\u00e2ni a ar\u0103tat c\u0103 aproape jum\u0103tate dintre adul\u021bi (48%) care au luat Wegovy au pierdut aproximativ 15% din greutatea lor corporal\u0103 ini\u021bial\u0103. Wegovy este acum unul dintre cele mai cunoscute \u0219i populare medicamente pentru pierderea \u00een greutate. Dac\u0103 faci injec\u021bii cu Wegovy, \u00ee\u021bi \u00eembun\u0103t\u0103\u021be\u0219ti dieta \u0219i cre\u0219ti cantitatea de exerci\u021bii fizice, ai putea pierde p\u00e2n\u0103 la 15% din greutatea ta corporal\u0103 ini\u021bial\u0103 \u00een primul an de tratament.<\/p>\n<p>Ingredientul activ din Wegovy este Semaglutide. Acesta imit\u0103 un hormon numit GLP-1, care este produs \u00een mod natural de corpul t\u0103u \u0219i ac\u021bioneaz\u0103 asupra receptorilor din creier pentru a-\u021bi spune c\u0103 e\u0219ti s\u0103tul. Prin imitarea acestui hormon, Semaglutide poate activa receptorul GLP-1 \u0219i poate p\u0103c\u0103li corpul t\u0103u s\u0103 cread\u0103 c\u0103 nu \u00ee\u021bi este foame. Acest lucru poate reduce apetitul t\u0103u \u0219i face alimentele grase \u0219i dulci &#8211; care sunt de obicei bogate \u00een calorii &#8211; mai pu\u021bin tentante.<\/p>\n<p>Saxenda con\u021bine un ingredient activ numit Liraglutide. Acesta ac\u021bioneaz\u0103 de asemenea asupra receptorului GLP-1 pentru a reduce apetitul \u0219i a ajuta la oprirea supraaliment\u0103rii. Cercet\u0103rile au ar\u0103tat c\u0103 Saxenda, combinat\u0103 cu exerci\u021bii fizice crescute \u0219i o diet\u0103 \u00eembun\u0103t\u0103\u021bit\u0103, ar putea ajuta s\u0103 pierzi \u00eentre 5% \u0219i 10% din greutatea ta corporal\u0103 ini\u021bial\u0103 \u00een primul an de tratament.<\/p>\n<h2>Mysimba vs alte medicamente pentru pierderea \u00een greutate<\/h2>\n<p><a class=\"always-open-new-tab\"   href=\"\/ro\/product\/mysimba\"   rel=\"nofollow\">Mysimba<\/a> (naltrexon\/bupropion) este un medicament pentru pierderea \u00een greutate care se deosebe\u0219te de alte op\u021biuni precum Semaglutide (Wegovy, Ozempic) \u0219i Liraglutide (Saxenda) prin mecanismul s\u0103u de ac\u021biune, efectele secundare \u0219i eficacitate. Mysimba este un medicament combina\u021bie care afecteaz\u0103 chimia creierului pentru a reduce apetitul \u0219i a cre\u0219te cheltuielile energetice, \u00een timp ce agonistii receptorului GLP-1, precum Semaglutide \u0219i Liraglutide, ac\u021bioneaz\u0103 prin imitarea unui hormon din intestin care regleaz\u0103 apetitul \u0219i zah\u0103rul din s\u00e2nge.<\/p>\n<p>Mysimba (Naltrexon-bupropion) reduce semnificativ greutatea corporal\u0103 cu o cantitate mic\u0103, dar cre\u0219te semnificativ riscul de efecte secundare. Este necesar un proces riguros de supraveghere post-marketing. Diferen\u021bele cheie sunt:<\/p>\n<h4>Mecanism de Ac\u021biune<\/h4>\n<p>Mysimba ac\u021bioneaz\u0103 asupra creierului, \u00een timp ce agonistii receptorului GLP-1 ac\u021bioneaz\u0103 asupra intestinului.<\/p>\n<h4>Efecte Secundare Poten\u021biale<\/h4>\n<p>De\u0219i ambele au efecte secundare gastrointestinale similare, Mysimba poate avea un risc mai mare de efecte secundare psihiatrice.<\/p>\n<h4>Rezultate Pierdere \u00een Greutate<\/h4>\n<p>Agoni\u0219tii receptorului GLP-1 arat\u0103 \u00een general rezultate mai mari \u00een pierderea \u00een greutate dec\u00e2t Mysimba.<\/p>\n<h2>\u0218tiin\u021ba din spatele Agoni\u0219tilor GLP-1 \u0219i Pierderii \u00een Greutate<\/h2>\n<p>Agoni\u0219tii peptidului 1 asem\u0103n\u0103tor glucagonului (GLP-1) sunt o clas\u0103 de medicamente utilizate pentru a trata diabetul zaharat de tip 2 (T2DM) \u0219i obezitatea. Ca o clas\u0103 de medicamente, ele sunt printre mai multe op\u021biuni farmacologice pentru aceste boli endocrine. Func\u021bia agoni\u0219tilor GLP-1 este de a reduce nivelurile de glucoz\u0103 seric\u0103 \u0219i, astfel, de a gestiona metabolismul pacien\u021bilor afecta\u021bi.<\/p>\n<h3>Cum func\u021bioneaz\u0103 agoni\u0219tii GLP-1?<\/h3>\n<p>Pentru a \u00een\u021belege cum func\u021bioneaz\u0103 agoni\u0219tii GLP-1, este util s\u0103 \u00een\u021belegi cum func\u021bioneaz\u0103 hormonul GLP-1 care apare \u00een mod natural. GLP-1 este un hormon pe care \u00eel produce intestinul sub\u021bire. Are mai multe roluri, inclusiv:<\/p>\n<p>GLP-1 (peptidul 1 asem\u0103n\u0103tor glucagonului) joac\u0103 un rol crucial \u00een reglarea zah\u0103rului din s\u00e2nge \u0219i a apetitului. Acesta declan\u0219eaz\u0103 eliberarea de insulin\u0103 din pancreas, ajut\u00e2nd corpul s\u0103 transforme alimentele \u00een energie, \u00een timp ce scade nivelurile de glucoz\u0103 din s\u00e2nge; insuficienta insulin\u0103 poate duce la zah\u0103r din s\u00e2nge ridicat \u0219i diabet. \u00cen acela\u0219i timp, GLP-1 blocheaz\u0103 secre\u021bia de glucagon, prevenind excesul de glucoz\u0103 s\u0103 intre \u00een fluxul sanguin. \u00cen plus, \u00eencetine\u0219te golirea stomacului, reduc\u00e2nd rata la care glucoza din alimente este absorbit\u0103. Dincolo de controlul zah\u0103rului din s\u00e2nge, GLP-1 \u00eembun\u0103t\u0103\u021be\u0219te sa\u021bietatea ac\u021bion\u00e2nd asupra regiunilor creierului care proceseaz\u0103 semnalele de foame, ajut\u00e2nd oamenii s\u0103 se simt\u0103 mai s\u0103tui mai mult timp dup\u0103 ce au m\u00e2ncat. Aceste efecte combinate fac din GLP-1 o \u021bint\u0103 cheie pentru medicamentele de gestionare a diabetului \u0219i a greut\u0103\u021bii.<\/p>\n<h2>Considera\u021bii privind medicamentele pentru pierderea \u00een greutate<\/h2>\n<ul>\n<li>BMI egal sau mai mare de 30.<\/li>\n<li>BMI egal sau mai mare de 27 cu una sau mai multe condi\u021bii legate de obezitate (cum ar fi hipertensiunea arterial\u0103 sau diabetul)<\/li>\n<li>Nu au pierdut cel pu\u021bin 5% din greutatea corporal\u0103 total\u0103 \u00een trei p\u00e2n\u0103 la \u0219ase luni doar cu schimb\u0103ri \u00een stilul de via\u021b\u0103.<\/li>\n<\/ul>\n<p>Medicamentele precum Mounjaro, Ozempic, Wegovy, Saxenda \u0219i Mysimba func\u021bioneaz\u0103 prin mecanisme diferite, cum ar fi activarea receptorului GLP-1 sau modularea chimiei creierului pentru a ajuta la pierderea \u00een greutate atunci c\u00e2nd sunt combinate cu schimb\u0103ri \u00een stilul de via\u021b\u0103. Un furnizor de servicii medicale poate evalua factorii individuali de s\u0103n\u0103tate pentru a determina cea mai potrivit\u0103 op\u021biune.<\/p>\n<h2>Pierdere \u00een Greutate A\u0219teptat\u0103<\/h2>\n<p>C\u00e2t de mult\u0103 greutate po\u021bi pierde \u00een siguran\u021b\u0103 \u00eentr-o lun\u0103 variaz\u0103 de la o persoan\u0103 la alta. Cu toate acestea, cei mai mul\u021bi exper\u021bi \u00een s\u0103n\u0103tate \u0219i organiza\u021bii medicale recomand\u0103 un obiectiv de pierdere \u00een greutate de 1-2 livre, sau lbs (2.2-4.4 kilograme, sau kg) pe s\u0103pt\u0103m\u00e2n\u0103, ceea ce echivaleaz\u0103 cu 4-8 lbs (8.8-17.6 kg) pe lun\u0103. Aceast\u0103 vitez\u0103 ajut\u0103 la reducerea riscului de complica\u021bii \u0219i \u00eembun\u0103t\u0103\u021be\u0219te \u0219ansele de a men\u021bine greutatea pe termen lung.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medicamentele pentru pierderea \u00een greutate, cum ar fi Mounjaro (tirzepatide) \u0219i Ozempic (semaglutide), au c\u00e2\u0219tigat popularitate datorit\u0103 eficien\u021bei lor \u00een&#8230;<\/p>\n","protected":false},"author":13,"featured_media":1264,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"tags":[],"expert":[20],"tty_blog_category":[38],"tty_blog_tag":[],"class_list":["post-1263","tty_blog","type-tty_blog","status-publish","has-post-thumbnail","hentry","expert-dr-m-ahmed","tty_blog_category-sanatate-cronica-metabolica"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medicamente pentru Pierdere \u00een Greutate: Compararea celor Mai Bune Op\u021biuni - Transtoyou - RO<\/title>\n<meta name=\"description\" content=\"Compar\u0103 Mounjaro, Ozempic, Wegovy, Saxenda \u0219i Mysimba pentru pierderea \u00een greutate\u2014mecanisme, rezultate, efecte secundare \u0219i cine se calific\u0103.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medicamente pentru Pierdere \u00een Greutate: Compararea celor Mai Bune Op\u021biuni - Transtoyou - RO\" \/>\n<meta property=\"og:description\" content=\"Compar\u0103 Mounjaro, Ozempic, Wegovy, Saxenda \u0219i Mysimba pentru pierderea \u00een greutate\u2014mecanisme, rezultate, efecte secundare \u0219i cine se calific\u0103.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&amp;p=1263\" \/>\n<meta property=\"og:site_name\" content=\"Transtoyou - RO\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.transtoyou.com\/wp-content\/uploads\/sites\/13\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263\",\"url\":\"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263\",\"name\":\"Medicamente pentru Pierdere \u00een Greutate: Compararea celor Mai Bune Op\u021biuni - Transtoyou - RO\",\"isPartOf\":{\"@id\":\"https:\/\/www.transtoyou.com\/ro\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.transtoyou.com\/ro\/wp-content\/uploads\/sites\/13\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png\",\"datePublished\":\"2026-01-26T21:22:03+00:00\",\"description\":\"Compar\u0103 Mounjaro, Ozempic, Wegovy, Saxenda \u0219i Mysimba pentru pierderea \u00een greutate\u2014mecanisme, rezultate, efecte secundare \u0219i cine se calific\u0103.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263#primaryimage\",\"url\":\"https:\/\/www.transtoyou.com\/ro\/wp-content\/uploads\/sites\/13\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png\",\"contentUrl\":\"https:\/\/www.transtoyou.com\/ro\/wp-content\/uploads\/sites\/13\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png\",\"width\":1024,\"height\":1024,\"caption\":\"Ilustra\u021bie a unui medic pe un smartphone care sf\u0103tuie\u0219te un b\u0103rbat despre pierderea \u00een greutate, cu sticle de medicamente, pastile, o balan\u021b\u0103 \u0219i icoane de s\u0103n\u0103tate.\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.transtoyou.com\/ro\/#website\",\"url\":\"https:\/\/www.transtoyou.com\/ro\/\",\"name\":\"Transtoyou - RO\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.transtoyou.com\/ro\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.transtoyou.com\/ro\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.transtoyou.com\/ro\/#organization\",\"name\":\"Transtoyou - RO\",\"url\":\"https:\/\/www.transtoyou.com\/ro\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/www.transtoyou.com\/ro\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.transtoyou.com\/ro\/wp-content\/uploads\/sites\/13\/2026\/01\/logo-tty-menu-bar-300x87-1.webp\",\"contentUrl\":\"https:\/\/www.transtoyou.com\/ro\/wp-content\/uploads\/sites\/13\/2026\/01\/logo-tty-menu-bar-300x87-1.webp\",\"width\":300,\"height\":87,\"caption\":\"Transtoyou - RO\"},\"image\":{\"@id\":\"https:\/\/www.transtoyou.com\/ro\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medicamente pentru Pierdere \u00een Greutate: Compararea celor Mai Bune Op\u021biuni - Transtoyou - RO","description":"Compar\u0103 Mounjaro, Ozempic, Wegovy, Saxenda \u0219i Mysimba pentru pierderea \u00een greutate\u2014mecanisme, rezultate, efecte secundare \u0219i cine se calific\u0103.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"ro_RO","og_type":"article","og_title":"Medicamente pentru Pierdere \u00een Greutate: Compararea celor Mai Bune Op\u021biuni - Transtoyou - RO","og_description":"Compar\u0103 Mounjaro, Ozempic, Wegovy, Saxenda \u0219i Mysimba pentru pierderea \u00een greutate\u2014mecanisme, rezultate, efecte secundare \u0219i cine se calific\u0103.","og_url":"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263","og_site_name":"Transtoyou - RO","og_image":[{"width":1024,"height":1024,"url":"https:\/\/www.transtoyou.com\/wp-content\/uploads\/sites\/13\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Timp estimat pentru citire":"5 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263","url":"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263","name":"Medicamente pentru Pierdere \u00een Greutate: Compararea celor Mai Bune Op\u021biuni - Transtoyou - RO","isPartOf":{"@id":"https:\/\/www.transtoyou.com\/ro\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263#primaryimage"},"image":{"@id":"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263#primaryimage"},"thumbnailUrl":"https:\/\/www.transtoyou.com\/ro\/wp-content\/uploads\/sites\/13\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png","datePublished":"2026-01-26T21:22:03+00:00","description":"Compar\u0103 Mounjaro, Ozempic, Wegovy, Saxenda \u0219i Mysimba pentru pierderea \u00een greutate\u2014mecanisme, rezultate, efecte secundare \u0219i cine se calific\u0103.","breadcrumb":{"@id":"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/www.transtoyou.com\/ro\/?post_type=tty_blog&p=1263#primaryimage","url":"https:\/\/www.transtoyou.com\/ro\/wp-content\/uploads\/sites\/13\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png","contentUrl":"https:\/\/www.transtoyou.com\/ro\/wp-content\/uploads\/sites\/13\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png","width":1024,"height":1024,"caption":"Ilustra\u021bie a unui medic pe un smartphone care sf\u0103tuie\u0219te un b\u0103rbat despre pierderea \u00een greutate, cu sticle de medicamente, pastile, o balan\u021b\u0103 \u0219i icoane de s\u0103n\u0103tate."},{"@type":"WebSite","@id":"https:\/\/www.transtoyou.com\/ro\/#website","url":"https:\/\/www.transtoyou.com\/ro\/","name":"Transtoyou - RO","description":"","publisher":{"@id":"https:\/\/www.transtoyou.com\/ro\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.transtoyou.com\/ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Organization","@id":"https:\/\/www.transtoyou.com\/ro\/#organization","name":"Transtoyou - RO","url":"https:\/\/www.transtoyou.com\/ro\/","logo":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/www.transtoyou.com\/ro\/#\/schema\/logo\/image\/","url":"https:\/\/www.transtoyou.com\/ro\/wp-content\/uploads\/sites\/13\/2026\/01\/logo-tty-menu-bar-300x87-1.webp","contentUrl":"https:\/\/www.transtoyou.com\/ro\/wp-content\/uploads\/sites\/13\/2026\/01\/logo-tty-menu-bar-300x87-1.webp","width":300,"height":87,"caption":"Transtoyou - RO"},"image":{"@id":"https:\/\/www.transtoyou.com\/ro\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.transtoyou.com\/ro\/wp-json\/wp\/v2\/tty_blog\/1263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transtoyou.com\/ro\/wp-json\/wp\/v2\/tty_blog"}],"about":[{"href":"https:\/\/www.transtoyou.com\/ro\/wp-json\/wp\/v2\/types\/tty_blog"}],"author":[{"embeddable":true,"href":"https:\/\/www.transtoyou.com\/ro\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transtoyou.com\/ro\/wp-json\/wp\/v2\/comments?post=1263"}],"version-history":[{"count":1,"href":"https:\/\/www.transtoyou.com\/ro\/wp-json\/wp\/v2\/tty_blog\/1263\/revisions"}],"predecessor-version":[{"id":1265,"href":"https:\/\/www.transtoyou.com\/ro\/wp-json\/wp\/v2\/tty_blog\/1263\/revisions\/1265"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.transtoyou.com\/ro\/wp-json\/wp\/v2\/media\/1264"}],"wp:attachment":[{"href":"https:\/\/www.transtoyou.com\/ro\/wp-json\/wp\/v2\/media?parent=1263"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transtoyou.com\/ro\/wp-json\/wp\/v2\/tags?post=1263"},{"taxonomy":"expert","embeddable":true,"href":"https:\/\/www.transtoyou.com\/ro\/wp-json\/wp\/v2\/expert?post=1263"},{"taxonomy":"tty_blog_category","embeddable":true,"href":"https:\/\/www.transtoyou.com\/ro\/wp-json\/wp\/v2\/tty_blog_category?post=1263"},{"taxonomy":"tty_blog_tag","embeddable":true,"href":"https:\/\/www.transtoyou.com\/ro\/wp-json\/wp\/v2\/tty_blog_tag?post=1263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}